March 29, 2024 03:14 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi has mastered art of manipulating democracy, hurting Constitution: Mallikarjun Kharge | Mafia-turned-politician Mukhtar Ansari dies of cardiac arrest at 63 | NIA arrests key conspirator in Bengaluru cafe blast case | Actor Govinda returns to politics after 14 years of 'vanvas', joins Eknath Shinde camp | 'To browbeat and bully others is vintage Congress culture': PM posts after 600 lawyers write to CJI
US health regulator calls for pause in Johnson & Johnson vaccine use after cases of rare blood clots Johnson&Johnson Vaccine
Image Credit: Pixabay

US health regulator calls for pause in Johnson & Johnson vaccine use after cases of rare blood clots

India Blooms News Service | @indiablooms | 13 Apr 2021, 10:57 pm

Washington/IBNS: US's federal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine after several cases of a rare and severe type of blood clot were reported among 6.8 million people who received the vaccine.

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are now reviewing reports of six cases of a rare and severe type of blood clot among those who have received the jabs of Johnson & Johnson.

European health regulators are also investigating three additional cases of blood clots, Johnson & Johnson said adding that they are delaying the rollout of the vaccine there.

All six cases in the US occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a statement issued by the FDA and CDC.

"Peter Marks, a top vaccine official at the FDA, said the clots are extremely similar to blood clots paired with low platelets that European regulators and scientists have determined are possibly triggered by an immune reaction to a separate vaccine developed by AstraZeneca and the University of Oxford," the Washington Post reported.

Earlier in March, several European countries like Denmark, Norway, Austria, Netherlands and Iceland had temporarily suspended the use of Oxford-AstraZeneca's Covid-19 vaccine over concerns about patients suffering from post-jab blood clots.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.